Genetic Basis And Inheritance Patterns Of Acrodysostosis: Understanding A Rare Condition
Published on: August 21, 2025
Genetic Basis And Inheritance Patterns Of Acrodysostosis: Understanding A Rare Condition
Article author photo

Masouma Mohamed Nazar

Medical genetics BSc Honours, Queen Mary University of London

Article reviewer photo

Pankti Shah

Doctor of Pharmacy (PharmD), Medical Writer, London, UK

Introduction

Acrodysostosis (ADO) is a rare genetic disorder in which there is abnormal development of the skeleton. Individuals with the affected disorder share characteristic features such as short fingers, underdevelopment of the nasal tissue and bones. This article aims to explain the genetic ‘make-up’ and inheritance patterns of ADO.1

What is acrodysostosis?

Acrodysostosis is a condition where the bones, particularly in the hands, feet, and face, develop abnormally. People with acrodysostosis often have a shorter stature, unique facial features, and sometimes intellectual disabilities or hormonal issues. Understanding the genetic roots of this disorder can help us comprehend why it occurs and how it is passed down in families.

The genetic basis of acrodysostosis

The genetic foundation of a situation refers to how unique genes and their mutations cause or contribute to the development of a disorder or a disease. Genes are made of DNA and bring instructions for constructing and retaining the frame. Mutations (abnormal changes within the DNA series) can disrupt the normal function of genes, leading to health issues. Genetic disorders can be inherited in numerous ways, including autosomal dominant, autosomal recessive, X-linked, and mitochondrial inheritance. 

Genes have different types of characteristics, and when one is mutated (altered), it changes the ‘make-up’ of the individual. There are some mutations that have no effect on the characteristic shown, but most have damaging effects. For example, acrodysostosis is primarily caused by mutations (changes) in specific genes that play crucial roles in bone development. The two main genes associated with acrodysostosis are PRKAR1A and PDE4D. Both of these genes are involved in signalling pathways that regulate bone growth and development. When there is a mutation in one of these genes, it disrupts the normal process, leading to the symptoms seen in acrodysostosis. The PDE4D gene is found to be associated with the underdevelopment of the nasal tissue and bones, as well as neurological impact. 

How do these mutations occur?

Mutations arise via diverse mechanisms and might occur at any point in someone's lifetime. They may additionally arise spontaneously due to mistakes during DNA replication, mainly due to background radiation, or interaction with chemical substances. Mutations can also be prompted via outside elements, along with excessive levels of radiation, chemical mutagens like the ones in tobacco smoke, and positive viral infections. Inherited mutations (also referred to as germline mutations) arise in reproductive cells and are handed from either parent to offspring; at the same time as new mutations can arise inside the reproductive cells, for example, in the fertilised egg itself. Additionally, mistakes in DNA restore mechanisms and structural adjustments in chromosomes can result in mutations. These genetic modifications can be harmless, beneficial, or dangerous, probably leading to numerous diseases or problems.

Inheritance patterns of acrodysostosis

Acrodysostosis follows an autosomal dominant inheritance pattern. But what does Autosomal dominance mean? :

Autosomal

This means the gene associated with acrodysostosis is located on one of the 22 pairs of chromosomes that are not involved in determining a person's sex. Both males and females have the same likelihood of being affected.

Dominant

A dominant disorder means that only one copy of the mutated gene is sufficient to cause the condition. Every individual has two copies of every gene (one from each parent). If a person inherits a mutated gene from just one parent, they will develop acrodysostosis.

Family implications

As this is an autosomal dominant genetic disorder, there is a 50% chance that the parent will pass the mutated gene to their child. This is because each parent randomly passes one of their two gene copies to their offspring. If the child inherits the mutated gene, they will have acrodysostosis.

Sporadic cases

In some instances, acrodysostosis occurs in people with no family history of the condition. These cases are often due to new (spontaneous) mutations in the PRKAR1A or PDE4D genes. These new mutations can occur in the reproductive cells of the parents or during the early stages of the child's development.

Diagnosing acrodysostosis

Acrodysostosis is identified via various clinical evaluations, for example, imaging studies and genetic testing. Doctors begin with a bodily examination to perceive features and functions, inclusive of short stature, brachydactyly (quick fingers and feet), and unique facial features. Medical history and family history are reviewed to become aware of any patterns. X-rays and different imaging studies like CT scans or MRIs assist in visualising bizarre bone boom. Genetic tests are vital for confirming the prognosis with the aid of identifying mutations in the PRKAR1A or PDE4D genes. Specialists, consisting of geneticists and endocrinologists, may be consulted for further evaluation and management. Blood tests for hormone levels and developmental assessments for kids are also a part of the diagnostic technique to ensure a complete understanding of the individual's condition. 

Managing acrodysostosis

Management of acrodysostosis focuses on addressing the diverse symptoms and headaches related to the condition, as there is no therapy. A multidisciplinary team involving different healthcare experts is often essential to offer complete care. Here’s an overview of the way the situation is controlled:

Medical management

  • Hormone Therapy: If hormonal imbalances are present together with resistance to parathyroid hormone or boom hormone deficiencies, suitable hormone therapies may be prescribed to control those troubles
  • Medications: Pain relievers and anti-inflammatory medications can help manage bone pain and discomfort

Physical and occupational therapy

  • Physical Therapy: Regular physical therapy classes can improve mobility, power, and typical bodily function, assisting people in controlling signs associated with bone and joint abnormalities
  • Occupational Therapy: Occupational therapists can help with growing competencies needed for daily living and improving fine motor skills, which may be specifically beneficial for individuals with brachydactyly

Educational support

  • Special Education Services: Children with intellectual or developmental delays can also benefit from individualised training plans (IEPs) and unique training offerings to help them understand and develop
  • Developmental Therapies: Speech therapy, behavioural therapy, and other developmental treatment options may be useful in addressing unique developmental demanding situations

Orthopaedic care

Orthopaedic Interventions: In a few cases, surgical techniques may be essential to accurate excessive bone deformities or to cope with issues with mobility. Orthopaedic surgeons can provide specialised care tailored to the individuals’ opinions.

Summary

Acrodysostosis is a rare genetic disease with a clear genetic foundation regarding mutations in the PRKAR1A or PDE4D genes. It follows an autosomal dominant inheritance pattern, which means that one copy of the mutated gene is needed to cause the condition. Understanding the genetic basis and inheritance styles of acrodysostosis can help families understand the situation and seek appropriate hospital therapy.

If you or someone you understand is affected by acrodysostosis, genetic counselling can provide valuable information. Genetic counsellors can assist in determining the risk of passing the condition to future children and speak of possible alternatives for family planning.

By increasing consciousness of the genetic basis and inheritance styles of acrodysostosis, we can foster an extra supportive environment for people and families afflicted with this rare condition.

References

  1. Linglart, Agnès, et al. ‘Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance’. New England Journal of Medicine, vol. 364, no. 23, June 2011, pp. 2218–26. DOI.org (Crossref), https://doi.org/10.1056/NEJMoa1012717.
  2. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, et al. Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance. N Engl J Med [Internet]. 2011 [cited 2025 Feb 18]; 364(23):2218–26. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1012717.
  3. Lynch, Danielle C., et al. ‘Identification of Novel Mutations Confirms Pde4d as a Major Gene Causing Acrodysostosis: HUMAN MUTATION’. Human Mutation, vol. 34, no. 1, Jan. 2013, pp. 97–102. DOI.org (Crossref), https://doi.org/10.1002/humu.22222.
  4. Lynch DC, Dyment DA, Huang L, Nikkel SM, Lacombe D, Campeau PM, et al. Identification of Novel Mutations Confirms Pde4d as a Major Gene Causing Acrodysostosis: HUMAN MUTATION. Human Mutation [Internet]. 2013 [cited 2025 Feb 18]; 34(1):97–102. Available from: https://onlinelibrary.wiley.com/doi/10.1002/humu.22222.
  5. Petraitytė, Gunda, et al. ‘A Novel Variant in the PDE4D Gene Is the Cause of Acrodysostosis Type 2 in a Lithuanian Patient: A Case Report’. BMC Endocrine Disorders, vol. 21, Apr. 2021, p. 71. PubMed Central, https://doi.org/10.1186/s12902-021-00741-6.
  6. Petraitytė G, Šiaurytė K, Mikštienė V, Cimbalistienė L, Kriaučiūnienė D, Matulevičienė A, et al. A novel variant in the PDE4D gene is the cause of Acrodysostosis type 2 in a Lithuanian patient: a case report. BMC Endocrine Disorders [Internet]. 2021 [cited 2025 Feb 18]; 21(1):71. Available from: https://doi.org/10.1186/s12902-021-00741-6.
  7. Silve, C., et al. ‘Acrodysostosis’. Hormone and Metabolic Research, vol. 44, no. 10, Sept. 2012, pp. 749–58. www.thieme-connect.com, https://doi.org/10.1055/s-0032-1316330.
  8. Silve C, Clauser E, Linglart A. Acrodysostosis. Horm Metab Res [Internet]. 2012 [cited 2025 Feb 18]; 44(10):749–58. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0032-1316330.
  9. Silve, C., et al. ‘Acrodysostosis Syndromes’. BoneKEy Reports, vol. 1, Nov. 2012, p. 225. PubMed Central, https://doi.org/10.1038/bonekey.2012.225.
  10. Silve C, Le-Stunff C, Motte E, Gunes Y, Linglart A, Clauser E. Acrodysostosis syndromes. Bonekey Rep [Internet]. 2012 [cited 2025 Feb 19]; 1:225. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868876/
Share

Masouma Mohamed Nazar

Medical genetics BSc Honours, Queen Mary University of London

Masouma Mohamed Nazar is a writer with a background in healthcare, genetics, and scientific communication. With a degree in Medical Genetics, she is passionate about pursuing a career in patient-facing roles, where she can combine her scientific knowledge with her dedication to improving patient care. Her experience spans clinical trials and patient support, and she is committed to making complex healthcare topics accessible and engaging for all readers.

arrow-right